Gilead Sciences, Inc. : Gilead Announces Phase 2 Results for Sofosbuvir-Based …4-traders (press release)In a second study conducted among post-transplant HCV patients (Study 0126), patients with established recurrent HCV infection following liver tra…
Top News From ACR 2013: Slideshow – Medscape
MedscapeTop News From ACR 2013: SlideshowMedscapeRituximab (Rituxan, Genentech) is a potential treatment option in immunoglobulin G4-related disease (IgG4), say researchers reporting first evidence. Lead investigator John Stone, MD, from Massachusetts …
OpportunityAnalyzer: Late-Stage Chronic Kidney Disease (CKD) – Opportunity … – PR Carbon (press release)
|
OpportunityAnalyzer: Late-Stage Chronic Kidney Disease (CKD) – Opportunity …
PR Carbon (press release) FOR IMMEDIATE RELEASE, Illinois – United States – November 8, 2013 (PR Carbon):Reportstack has announced a new market report on OpportunityAnalyzer: Late-Stage Chronic Kidney Disease (CKD) – Opportunity Analysis and Forecasts to 2017. |
Pfizer Inc. : Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of … – 4-traders (press release)
Drug Discovery & Development |
Pfizer Inc. : Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of …
4-traders (press release) Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant. The primary … Pfizer Inc. (NYSE:PFE) | Pfizer Announces Top-Line Results Of Phase 3B/4 …Jutia Group Pfizer says organ transplant drug fails in studyBusinessweek Pfizer’s Rapamune Doesn’t Meet Primary Endpoint in Study of Kidney Transplant …Wall Street Journal |
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R … – MarketWatch
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R …MarketWatchNEW YORK, Nov 08, 2013 (BUSINESS WIRE) — Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE(R) (sirolimus) evaluating kidney tra…
Award for organ donor campaign – Illawarra Mercury
Award for organ donor campaignIllawarra MercuryThe Discovering and Discussing Organ Donation Together project was announced the winner of the government category at the National Multicultural Marketing Awards at a gala event in Sydney on Thursday night…
Diana gets out of bed, walks around the hospital – Mid-Hudson News
|
Diana gets out of bed, walks around the hospital
Mid-Hudson News NEW YORK – Orange County Executive Edward Diana continues to make progress in recovery from liver transplant surgery last Saturday at Columbia Presbyterian Hospital in New York, his family reports. Diana has begun working with a physical therapist … |
TB: 'There is a clearly higher risk of mortality in children of 0-4 years' – The Hindu
The Hindu |
TB: ‘There is a clearly higher risk of mortality in children of 0-4 years’
The Hindu This is despite the fact that we know one third of the global population (and nearly 40 per cent of the Indian population) is estimated to be latently infected with TB. Since 5-20 per cent of these latently infected people develop … The global health … |
Asan leading medical 'hallyu' – Korea Times
Korea Times |
Asan leading medical ‘hallyu’
Korea Times “In some transplant surgery, we are on a par with Johns Hopkins or MD Anderson while the treatment expense is less than one-third of the top global hospitals,” said Prof. Kim who specializes in gynecological cancer. Around 10,000 foreign patients were … |
Verfiying grandma's pearls of wisdom – Times of India
Times of India |
Verfiying grandma’s pearls of wisdom
Times of India Cod liver oil can help reduce pain in joints. According to researchers at Cardiff, 86 per cent of patients who took 2,000 mg of cod liver oil capsules every day had reduced levels of one of the enzymes that cause cartilage damage, compared to only 26 … |